Gilead Releases Positive Findings With Coronavirus Patients

As pressure mounts on the Trump administration to follow through on “Operation Warp Speed,” the pharmaceutical community is working overtime to develop, test and approve a vaccine. Making arguable the most progress towards a viable solution has been Gilead Science (GILD) and their antiviral drug, remdesivir. And today, they delivered investors, and more importantly COVID-19

Read More ›

Market Overview